CoChat

The RNA exosome: mechanisms of RNA surveillance, regulation, and disease

Open access

The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index; none of the 275 sources its claims cite is checked for support yet.

Abstract

The RNA exosome is a conserved multi-subunit ribonuclease complex with pivotal roles in RNA biogenesis, surveillance, and processing. It comprises a nine-subunit scaffold that associates with distinct ribonucleases in a cell compartment-specific manner, contributing to the processing and turnover of a broad spectrum of nuclear and cytoplasmic transcripts, including pervasively transcribed and short-lived RNAs, precursors, and abortive and aberrant transcripts. In this review, we examine how the RNA exosome engages a wide spectrum of RNAs via differential adaptor usage and intrinsic substrate features, such as transcript length and 3’ end structure. This also modulates the entry routes of the recruited transcripts. We highlight conserved principles and major differences between yeast and metazoans. We assimilate emerging evidence that suggests that the RNA exosome localization and activity are dynamically regulated in response to cellular context and external stimuli. Finally, drawing on findings from studies in S. cerevisiae, Drosophila, zebrafish, and mice, we discuss how perturbations in RNA surveillance can result in abnormalities in organismal development and homoeostasis. Together, these studies not only enhance our knowledge of the broader relevance of RNA quality control and metabolism but also provide mechanistic insights into pathomechanisms, particularly the tissue-specific vulnerabilities noted in RNA exosome-linked diseases.

Overview

CoChat Summary

TL;DR

This review synthesizes current understanding of the RNA exosome — a conserved nine-subunit ribonuclease complex — covering its architecture, adaptor-dependent substrate selection, nuclear and cytoplasmic entry routes, regulation by localization and post-translational modification, and its links to human disease. It argues that the exosome is an actively regulated modulator of gene expression rather than a passive disposal unit, and that tissue-specific vulnerabilities explain the disparate phenotypes of RNA exosomopathies.

Key findings

  • The EXO9 core is a six-subunit PH-domain barrel (EXOSC4–EXOSC9) with an 8–10 Å central channel that accommodates a single RNA strand, capped by three S1-KH-domain subunits (EXOSC1–EXOSC3); it recruits EXOSC10, DIS3, or DIS3L1 in a mutually exclusive, compartment-specific manner (nucleolus, nucleoplasm, cytoplasm respectively).
  • Substrate routing depends on intrinsic RNA features and adaptor engagement: short, capped, poorly polyadenylated transcripts (e.g., TSSa-RNAs of ~20–200 nt, eRNAs of ~500 nt) are targeted by NEXT via CBC/ARS2, whereas longer, polyadenylated species (e.g., PROMPTs of ~450 nt) are preferentially degraded by PAXT; unstructured substrates with short 3′ extensions access Rrp44/DIS3 directly, while structured RNAs with longer 3′ tails are threaded through the EXO9 channel.
  • Exosome activity is dynamically regulated: phosphorylation sites are reported on yCsl4, yRrp4, yRrp43, yMtr3, yRrp6 and ySki7, and PTM profiling of the purified S. pombe exosome revealed 39 modified sites; SUMOylation of EXOSC10 at K583 (via USP36) is required for nucleolar function, and hypoxia triggers its deSUMOylation and nucleolar-to-nucleoplasmic translocation.
  • Exosome dysfunction causes monogenic disease with tissue-specific phenotypes — EXOSC1/3/8/9 variants cause PCH1 subtypes (PCH1F, PCH1B, PCH1C, PCH1D), EXOSC2 variants cause SHRF, EXOSC5 variants cause CABAC, ZCCHC8 variants cause pulmonary fibrosis/bone marrow failure, and SKIV2L/TTC37 variants cause trichohepatoenteric syndrome 2 and 1 — while DIS3 mutations are found in up to 18% of multiple myeloma cases.

Methods

  • Narrative review; no primary experimental data are generated. The authors integrate structural, biochemical, transcriptomic, and genetic findings from the published literature.
  • Evidence is drawn across model systems — S. cerevisiae, S. pombe, Drosophila melanogaster, Danio rerio, Mus musculus, and human cells — with a summary table (Table 1) mapping human exosome and cofactor subunits to their orthologs in mouse, zebrafish, Drosophila, and budding yeast alongside OMIM disease associations.
  • Disease coverage is explicitly scoped to monogenic disorders and cancers.

Limitations

  • Stated by the paper: key conceptual gaps remain, including how individual substrates are selectively routed to distinct exosome arms and cofactors (TRAMP, NEXT, PAXT, SKI) or via translation-dependent quality control; the authors call for high-resolution structural/biochemical work, CRISPR/Cas9 editing at defined target loci with nascent RNA sequencing and long-read profiling, and single-nucleus sequencing with patient-derived iPSCs and organoids to probe tissue-specific vulnerabilities.
  • Stated by the paper: it is unclear whether the yeast TRAMP–Rrp6/Rrp47 interaction is conserved in humans, whether an analogous splicing-surveillance pathway to yeast Gbp2/Hrb1 operates in complex organisms, and whether Mpp6 coordinates Mtr4–exosome interaction in yeast as it does in metazoans; whether nuclear import of the exosome occurs as a pre-assembled complex, subcomplexes, or individual subunits is also not well understood.
  • Evident from the text: as a review, all conclusions rest on previously published studies rather than new data, and the disease discussion is deliberately restricted to monogenic disorders and cancers, leaving other disease contexts and non-DIS3 cancer mechanisms largely unaddressed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/15476286.2026.2685379

Cites

207 of 207 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Architecture of the human RNA exosome and its cofactors. A. schematic representation of the RNA exosome that comprises a nine-subunit scaffold (EXO9): a six-subunit PH-domain containing barrel (EXOSC4-EXOSC9) with a central channel through which a single RNA substrate can be threaded and capped by three S1-KH-domain-containing subunits (EXOSC1-EXOSC3). This associates with distinct 3’-5’ nucleases: the exoribonuclease EXOSC10 binds the cap, DIS3 with endo- and exoribonuclease, and DIS3L1 with exoribonuclease, that associate with the base of EXO9, in a mutually exclusive manner. B. RNA exosome cofactor assemblies and catalytic subunits with their subcellular localization. EXOSC10, DIS3 and DIS3L1 preferentially associate with EXO9 in the nucleolus, nucleoplasm and cytoplasm, respectively. The RNA helicase MTR4 is shared across several distinct nuclear exosome cofactor assemblies in a mutually exclusive manner: in the nucleolus it combines with ZCCHC7 and hTRF4-2 to form the human TRAMP-like complex; in the nucleoplasm it is incorporated in the NEXT and PAXT adaptor complexes by binding ZCCHC8 and ZFC3H1 RNA-binding proteins, respectively. In the cytoplasm the SKI complex is composed of SKIV2L, TTC37 and WDR61 that are orthologous to the budding yeast ySki2, ySki3, and ySki8 and associate with the exosome for its function.
Figure 1. Architecture of the human RNA exosome and its cofactors. A. schematic representation of the RNA exosome that comprises a nine-subunit scaffold (EXO9): a six-subunit PH-domain containing barrel (EXOSC4-EXOSC9) with a central channel through which a single RNA substrate can be threaded and capped by three S1-KH-domain-containing subunits (EXOSC1-EXOSC3). This associates with distinct 3’-5’ nucleases: the exoribonuclease EXOSC10 binds the cap, DIS3 with endo- and exoribonuclease, and DIS3L1 with exoribonuclease, that associate with the base of EXO9, in a mutually exclusive manner. B. RNA exosome cofactor assemblies and catalytic subunits with their subcellular localization. EXOSC10, DIS3 and DIS3L1 preferentially associate with EXO9 in the nucleolus, nucleoplasm and cytoplasm, respectively. The RNA helicase MTR4 is shared across several distinct nuclear exosome cofactor assemblies in a mutually exclusive manner: in the nucleolus it combines with ZCCHC7 and hTRF4-2 to form the human TRAMP-like complex; in the nucleoplasm it is incorporated in the NEXT and PAXT adaptor complexes by binding ZCCHC8 and ZFC3H1 RNA-binding proteins, respectively. In the cytoplasm the SKI complex is composed of SKIV2L, TTC37 and WDR61 that are orthologous to the budding yeast ySki2, ySki3, and ySki8 and associate with the exosome for its function.CC BY · PubMed Central
Figure 2. Overview of RNA exosome adaptor usage for targeting varied RNA species. Nuclear surveillance monitors pervasively transcribed short-lived RNAs, such as PROMPTs, TSSa-RNAs, and eRNAs, arising from the TSS and promoter-proximal paused regions. Early transcription termination events mediated by the Integrator and Restrictor complexes also result in unstable RNA species, while PCPA generates longer and more polyadenylated RNAs. Different RNA species are selectively recognized by distinct adaptor pathways engaged with the RNA exosome. The NEXT complex (hMTR4–ZCCHC8–RBM7), together with the CBC and ARS2, targets short, capped, and poly(A) deficient transcripts, such as PROMPTs, TSSa-RNAs, and eRNAs. The PAXT machinery (hMTR4–ZFC3H1–RBM26/27–PABPN1) predominantly targets longer, and more polyadenylated nuclear RNAs. In addition, transcripts derived from genomic regions enriched in transposable elements (TE) or TE-RNAs are decayed through the HUSH complex (TASOR-PPHLN1-MPP8), which can interface with NEXT-mediated exosome recruitment, at transcriptional and post-transcriptional stages. HUSH is recruited to TE loci enriched with H3K9me3 repressive histone modifications by SETDB1. NEXT is engaged by HUSH through the interaction between ZCCHC8 and MPP8.
Figure 2. Overview of RNA exosome adaptor usage for targeting varied RNA species. Nuclear surveillance monitors pervasively transcribed short-lived RNAs, such as PROMPTs, TSSa-RNAs, and eRNAs, arising from the TSS and promoter-proximal paused regions. Early transcription termination events mediated by the Integrator and Restrictor complexes also result in unstable RNA species, while PCPA generates longer and more polyadenylated RNAs. Different RNA species are selectively recognized by distinct adaptor pathways engaged with the RNA exosome. The NEXT complex (hMTR4–ZCCHC8–RBM7), together with the CBC and ARS2, targets short, capped, and poly(A) deficient transcripts, such as PROMPTs, TSSa-RNAs, and eRNAs. The PAXT machinery (hMTR4–ZFC3H1–RBM26/27–PABPN1) predominantly targets longer, and more polyadenylated nuclear RNAs. In addition, transcripts derived from genomic regions enriched in transposable elements (TE) or TE-RNAs are decayed through the HUSH complex (TASOR-PPHLN1-MPP8), which can interface with NEXT-mediated exosome recruitment, at transcriptional and post-transcriptional stages. HUSH is recruited to TE loci enriched with H3K9me3 repressive histone modifications by SETDB1. NEXT is engaged by HUSH through the interaction between ZCCHC8 and MPP8.CC BY · PubMed Central
Figure 3. RNA exosome entry routes and mechanisms of adaptor and nuclease engagement. Schematic overview of mechanisms governing RNA substrate access to the exosome in budding yeast and humans. A. alternate RNA exosome entry routes (based on budding yeast): unstructured or less constrained transcripts with short 3’ extensions preferentially access yRrp44 ribonuclease directly, and structured substrates with longer 3’-tails are predominantly threaded through the EXO9 central channel to yRrp44. B. in addition to RNA features, adaptor also engagement influences exosome entry in budding yeast. During rRNA maturation, 5’ external spacer (5’ ETS) is co-transcriptionally excised from the pre-rRNA, it is oligoadenylated by TRAMP and preferentially threaded through the EXO9 channel to yRrp44, following which it is released from the channel, undergoes oligoadenylation by TRAMP again and targeted to yRrp44 directly. In parallel, structured RNA substrates, such as those arising by RNA Pol III transcription, such as primary tRNAs, are biased for yRrp44-exosome-mediated decay. In humans, unstable, capped transcripts RNA species, such as those generated by RNA Pol II are routed to the exosome depending on polyadenylation status: poly(A) poor RNAs are primarily recruited by NEXT, threaded through EXO9 channel and degraded by DIS3 in the nucleoplasm; a minority of these transcripts are degraded by EXOSC10 in the nucleolus; poly(A) enriched transcripts are recruited by MPP6-bound exosomes that engage PAXT and enhance delivery to DIS3 by channel-mediated translocation, in discreet PAXT-dependent foci.
Figure 3. RNA exosome entry routes and mechanisms of adaptor and nuclease engagement. Schematic overview of mechanisms governing RNA substrate access to the exosome in budding yeast and humans. A. alternate RNA exosome entry routes (based on budding yeast): unstructured or less constrained transcripts with short 3’ extensions preferentially access yRrp44 ribonuclease directly, and structured substrates with longer 3’-tails are predominantly threaded through the EXO9 central channel to yRrp44. B. in addition to RNA features, adaptor also engagement influences exosome entry in budding yeast. During rRNA maturation, 5’ external spacer (5’ ETS) is co-transcriptionally excised from the pre-rRNA, it is oligoadenylated by TRAMP and preferentially threaded through the EXO9 channel to yRrp44, following which it is released from the channel, undergoes oligoadenylation by TRAMP again and targeted to yRrp44 directly. In parallel, structured RNA substrates, such as those arising by RNA Pol III transcription, such as primary tRNAs, are biased for yRrp44-exosome-mediated decay. In humans, unstable, capped transcripts RNA species, such as those generated by RNA Pol II are routed to the exosome depending on polyadenylation status: poly(A) poor RNAs are primarily recruited by NEXT, threaded through EXO9 channel and degraded by DIS3 in the nucleoplasm; a minority of these transcripts are degraded by EXOSC10 in the nucleolus; poly(A) enriched transcripts are recruited by MPP6-bound exosomes that engage PAXT and enhance delivery to DIS3 by channel-mediated translocation, in discreet PAXT-dependent foci.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 1 Not valid · 176 Not checked · 38 Own results and interpretations

101 more claims

Create a free account to see all 215 claims and to verify the 275 references still open.

See all claims — free account
  • It may state two separate claims as one. 102
  • Probably not a substantial claim. 12

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 207 references

Cited by

See all 2

Metadata

Authors
Upadhyai, P., Quadri, N., & Chandran, D.
Affiliations
Manipal Academy of Higher Education (IN)
Corresponding author
Upadhyai, Priyanka
Venue
RNA Biology
Published
2026-06-11
Volume
23
Issue
1
Pages
1-24
ISSN
  • 1547-6286 (ISSN-L)
  • 1555-8584
OpenAlex
W7164348784
Cited by
2
References
207
Citations by year
2026: 2
FWCI
0.87
Type
journal article
Language
en
Open access
Locations
  • RNA Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Anusandhan National Research Foundation (ANRF), Government of India (CRG/2022/000793)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
Keywords
RNA exosome, RNA surveillance, RNA quality control, RNA processing, RNA turnover, transcript length, RNA biogenesis, aberrant transcripts, developmental abnormalities, homeostasis
MeSH terms
Animals, Gene Expression Regulation, Humans, RNA, RNA Stability, Exosomes, Exosome Multienzyme Ribonuclease Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The RNA exosome: mechanisms of RNA surveillance, regulation, and disease. https://app.cochat.ai/papers/10.1080/15476286.2026.2685379
The paper
Upadhyai, P., Quadri, N., & Chandran, D. (2026). The RNA exosome: mechanisms of RNA surveillance, regulation, and disease. RNA Biology. https://doi.org/10.1080/15476286.2026.2685379

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.